In 2023, the Acute Coronary Syndrome (ACS) treatment market reached a remarkable USD 9.60 billion, driven by the increasing prevalence of coronary heart disease worldwide. As projections indicate a CAGR of 6.05% from 2024 to 2032, the market is set to attain an estimated value of USD 16.30 billion by 2032. But what exactly is ACS, and how is this market evolving to address one of the...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek